Efficacy and Safety of Inhaled Insulin Therapy

  1. Harold Sox, MD, Editor

    IN RESPONSE:

    As a matter of editorial policy, we avoid doing anything that people would interpret as collusion with a commercial company to draw attention to their product. In the case of Rosenstock and colleagues' paper (1), we knew that the FDA had not yet approved inhaled insulin, but we had no idea when it would announce its decision. We could not and did not engineer the publication date to coincide with the FDA announcement.

     
    Next Section

    Harold Sox, MD

    Editor

    American College of Physicians

    Previous SectionNext Section

    Article and Author Information

    • Potential Financial Conflicts of Interest: None disclosed.

    Previous Section
     

    Reference

    1. 1.↵
      1. RosenstockJ,
      2. ZinmanB,
      3. MurphyLJ,
      4. ClementSC,
      5. MooreP,
      6. BoweringCK
      et al.Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial.Ann Intern Med2005143549-58pmid:16230721
      Rosenstock J, Zinman B, Murphy LJ, Clement SC, Moore P, Bowering CK, et al. Inhaled insulin improves glycemic control when substituted for or added to oral combination therapy in type 2 diabetes: a randomized, controlled trial. Ann Intern Med. 2005;143:549-58. [PMID: 16230721]
      Abstract/FREE Full Text
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med April 4, 2006 vol. 144 no. 7 533-
    1. ExcerptFREE
    2. » Full Text
    3. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Navigate This Article

    Current Issue

    1. November 3, 2009, 151 (9)
    1. Alert me to current issues